Eidos Therapeutics, Inc. is a company that provides Amyloidosis, Medicine, Transthyretin and more. Eidos Therapeutics, Inc. is headquartered in United States California. Eidos Therapeutics, Inc. was founded in 2013. Eidos Therapeutics, Inc. has a total of 66 patents
Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product...
What is Eidos Therapeutics, Inc.'s official website?